by MM360 Staff | May 1, 2025 | Uncategorized
Source: CureToday articles A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following progression on Gleevec. Read More
by MM360 Staff | May 1, 2025 | Uncategorized
Source: CureToday articles LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers. Read More
by MM360 Staff | Apr 30, 2025 | Uncategorized
Source: CureToday articles The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer. Read More
by MM360 Staff | Apr 30, 2025 | Uncategorized
Source: CureToday articles Patient and disease-related factors influence surgical recovery and treatment outcomes after Keytruda and Padcev in advanced urothelial cancer. Read More
by MM360 Staff | Apr 30, 2025 | Uncategorized
Source: CureToday articles Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing non–muscle-invasive bladder cancer. Read More
by MM360 Staff | Apr 30, 2025 | Uncategorized
Source: CureToday articles CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1 biomarkers, supporting a biomarker-driven phase 2b study. Read More
